Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myeloproliferative Disorders 3Primary Myelofibrosis 1Blast Crisis 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Busulfan 8Antilymphocyte Serum 8Mycophenolic Acid 7Whole-Body Irradiation 6Tacrolimus 6Methylprednisolone 6Methotrexate 6Cyclosporine 6Radiotherapy 5Filgrastim 5Cord Blood Stem Cell Transplantation 5Sirolimus 4Rituximab 4Flow Cytometry 4Cytarabine 4Thiotepa 3Melphalan 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Dasatinib 3venetoclax 2ponatinib 2aldesleukin 2Tretinoin 2Therapeutics 2Sunitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Blast Crisis × fedratinib × Clear all
NCT05524857 2024-04-23

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Columbia University

Phase 1 Terminated
2 enrolled
Myeloid

Blast Crisis, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡